Dog erythrocyte antigens 1.1, 1.2, 3, 4, 7, and Dal blood typing and cross‐matching by gel column technique

Background: Testing for canine blood types other than dog erythrocyte antigen 1.1 (DEA 1.1) is controversial and complicated by reagent availability and methodology. Objectives: The objectives of this study were to use available gel column technology to develop an extended blood‐typing method using polyclonal reagents for DEA 1.1, 1.2, 3, 4, 7, and Dal and to assess the use of gel columns for cross‐matching. Methods: Dogs (43–75) were typed for DEA 1.1, 1.2, 3, 4, 7, and Dal. Methods included tube agglutination (Tube) using polyclonal reagents, a commercially available DEA 1.1 gel column test kit (Standard‐Gel) using monoclonal reagent, and multiple gel columns (Extended‐Gel) using polyclonal reagents. Blood from 10 recipient and 15 donor dogs was typed as described above and cross‐matched using the gel column technique. Results: Of 43 dogs typed for DEA 1.1, 23, 25, and 20 dogs were positive using Standard‐Gel, Extended‐Gel, and Tube, respectively. Typing for DEA 1.2 was not achievable with Extended‐Gel. For 75 dogs typed for DEA 3, 4, and 7, concordance of Extended‐Gel with Tube was 94.7%, 100%, and 84%, respectively. Dal, determined only by Extended‐Gel, was positive for all dogs. Post‐transfusion major cross‐matches were incompatible in 10 of 14 pairings, but none were associated with demonstrable blood type incompatibilities. Conclusions: Gel column methodology can be adapted for use with polyclonal reagents for detecting DEA 1.1, 3, 4, 7, and Dal. Agglutination reactions are similar between Extended‐Gel and Tube, but are more easily interpreted with Extended‐Gel. When using gel columns for cross‐matching, incompatible blood cross‐matches can be detected following sensitization by transfusion, although in this study incompatibilities associated with any tested DEA or Dal antigens were not found.     

Variation of glucosinolates in wild radish (Raphanus raphanistrum) accessions

Glucosinolate composition was determined in wild radish accessions from eight states in the northeastern and southern United States to determine the variability of production among accessions. Glucosinolates were evaluated from roots, leaves, flowers, primary, and secondary branches. Seventeen glucosinolates were identified, with glucoerucin, glucoraphenin, glucobrassicin, and gluconasturtiin contributing 90% to 100% of the total glucosinolates. Flowers contained the highest glucosinolate concentrations, 12.07 to 55.36 μmol/g, but flowers contributed only 5.3 to 21.3% to the total glucosinolates. Of the eight accessions, the Mississippi accession produced significantly higher levels of total glucosinolates and glucosinolates which can be degraded to isothiocyanates per plant, totals of 618.97 and 563.53 μmol/plant, respectively. Total plant biomass did not differ between accessions indicating a difference in the ability of the Mississippi accession to produce glucosinolates. Further studies are needed to determine if this accession would consistently produce higher glucosinolate levels under different environmental conditions.     

Assessment of feeding varying levels of Metabolizable energy and protein on performance of transition Murrah buffaloes

Fifteen close up pregnant Murrah buffaloes of mean body weight (668.3 ± 24.03) kg, lactation number (2.8 ± 0.17) and expected producing ability (EPA) (2125.7 ± 46.34) were randomly distributed into three groups each of five animals to investigate the performance at different levels of metabolizable energy and protein. Control group was fed as per ICAR Nutrient requirements of animals (2013) recommendation whereas treatment group (1) high metabolizable energy and high metabolizable protein (HMEMP) and group (2) low metabolizable energy and low metabolizable protein (LMEMP) were offered with ration containing 15% more and 15% less ME and MP, respectively. The feeding trial was carried out for the period of 40 days before parturition and continued for 120 days after parturition. Intake of dry matter (DM) (%BW) was similar among experimental groups. Metabolizable energy (ME) (MJ/100 kg BW) and metabolizable protein (MP) (g/100 kg BW) intake was highest in HMEMP followed by control and LMEMP group, respectively. Digestibility trial of 7 days was conducted at 60 days post-partum and it was observed that apparent digestibility coefficients (%) of DM, organic matter (OM), crude protein (CP), ether extracts (EE), neutral detergent fiber (NDF) and acid detergent fiber (ADF) were similar among the experimental groups. Milk yield (kg/kg DMI) was similar among treatment groups whereas 6% fat corrected milk (FCM) was lower in LMEMP group as compared to HMEMP and control. No significant effect of dietary MP and ME levels on milk composition was observed among experimental groups. There were no significant difference in non esterified fatty acid (NEFA), blood urea nitrogen(BUN), growth hormone (GH) and insulin like growth factor-1(IGF-1) concentration among different experimental groups whereas concentration of immunoglobulin G (IgG) (μg/ml) was found to be lower in LMEMP. The study results indicate that nutrient digestibility and lactation performance was not affected with 15% variation in intakes of ME and MP in lactating Murrah buffaloes.     

Ileocolic junction resection in dogs and cats: 18 cases

There is limited veterinary literature about dogs or cats with ileocolic junction resection and its long-term follow-up. To evaluate the long-term outcome in a cohort of dogs and cats that underwent resection of the ileocolic junction without extensive (≥50%) small or large bowel resection. Medical records of dogs and cats that had the ileocolic junction resected were reviewed. Follow-up information was obtained either by telephone interview or e-mail correspondence with the referring veterinary surgeons. Nine dogs and nine cats were included. The most common cause of ileocolic junction resection was intussusception in dogs (5/9) and neoplasia in cats (6/9). Two dogs with ileocolic junction lymphoma died postoperatively. Only 2 of 15 animals, for which long-term follow-up information was available, had soft stools. However, three dogs with suspected chronic enteropathy required long-term treatment with hypoallergenic diets alone or in combination with medical treatment to avoid the development of diarrhoea. Four of 6 cats with ileocolic junction neoplasia were euthanised as a consequence of progressive disease. Dogs and cats undergoing ileocolic junction resection and surviving the perioperative period may have a good long-term outcome with mild or absent clinical signs but long-term medical management may be required.     

Splenectomy in the management of primary immune‐mediated hemolytic anemia and primary immune‐mediated thrombocytopenia in dogs

BackgroundCurrent reports about the use of splenectomy for the management of immune‐mediated hemolytic anemia (IMHA) or immune‐mediated thrombocytopenia (ITP) or both in dogs are limited.ObjectivesTo retrospectively describe the use of splenectomy as part of the management for IMHA, ITP, and concurrent IMHA and severe thrombocytopenia (CIST) in dogs. It was hypothesized that splenectomy would be beneficial in allowing for reduction of dose of immunosuppressive drugs or discontinuation in 1 or more of these groups.AnimalsSeventeen client‐owned dogs (7 with IMHA, 7 with ITP, and 3 with CIST) were identified across 7 UK‐based referral hospitals from a study period of 2005 to 2016.MethodsData were collected retrospectively via questionnaires and included information about diagnosis, management and treatment response before and after splenectomy. Based on clinical outcome, treatment with splenectomy as part of the management protocol was classified as either successful or unsuccessful.ResultsSix of 7 dogs with ITP were managed successfully with splenectomy as part of their management protocol (3 complete and 3 partial responses), although 1 subsequently developed suspected IMHA. Of the 7 dogs with IMHA, splenectomy was part of a successful management protocol in 4 dogs (2 complete and 2 partial responses). In the CIST group, 1 case (1/3) responded completely to management with splenectomy as part of the management protocol.Conclusions and Clinical ImportanceSplenectomy was considered successful and well tolerated in most cases of isolated ITP. Whether there is a benefit of splenectomy in cases of IMHA and CIST could not be determined in the current study.     

Engineered resistance against filamentous pathogens in Solanum tuberosum

Potato is one of the most important noncereal crops in the world today, and like other major crops, it is prone to substantial yield losses because of various factors including disease. Recent molecular advancements in plant–pathogen studies have led to the identification of various host genes involved in the plant’s defense against pathogen attack. These genes may encode antimicrobial peptides, enzymes for phytoalexin production, proteins involved in defense-signaling cascades, and hydrolytic enzymes or pathogenesis-related proteins that are directly or indirectly responsible for the plant’s defense responses following a pathogen attack. A plant’s disease-resistance (R) genes are another important group of genes that have been used with varying degrees of success in crop improvement programs. Cloning and characterization of these genes and the dissection of signal-transduction components of the defense response have greatly increased the scope for transgenic disease resistance. This article highlights the current scenario and potential of the molecular approaches to improve resistance against filamentous pathogens in potato.